Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex

European Journal of Pharmacology

Volumn 558, Issue 1-3, 2007, Pages 96-97

  Horner, Weldon E ^a   Johnson, David E ^a   Schmidt, Anne W ^a   Rollema, Hans ^a  

^a PFIZER INC   (United States)

Author keywords

ADHD; Atomoxetine; Histamine; Methylphenidate; Microdialysis

Indexed keywords

ATOMOXETINE; CIPROXIFAN; DOPAMINE; HISTAMINE; METHYLPHENIDATE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; HISTAMINE RELEASE; LEARNING; MALE; MEMORY; MICRODIALYSIS; NONHUMAN; NORADRENALIN BRAIN LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; HISTAMINE RELEASE; MALE; METHYLPHENIDATE; PREFRONTAL CORTEX; PROPYLAMINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33847320565     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.048     Document Type: Article

References (7)

1. Arnsten A.F.T. Fundamentals of Attention-Deficit/Hyperactivity Disorder: circuits and pathways. J. Clin. Psychiatry 67 suppl 8 (2006) 7-12
2. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F.T., Kelley A.E., Schmeichel B., Hamilton C., and Spencer R.C. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatry (2006) 10.1016/j.biopsych.2006.04.022
3. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., Morin S.M., Gehlert D.R., and Perry K.W. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27 (2002) 699-711
4. Leurs R., Bakker R.A., Timmerman H., and De Esch I.J.P. The histamine H3 receptor from gene cloning to H3 receptor drugs. Nat. Med. 4 (2005) 107-120
5. Swanson C.J., Perry K.W., Koch-Krueger S., Katner J., Svensson K.A., and Bymaster F.P. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology 50 (2006) 755-760
6. Westerink B.H.C., Cremers T.I.F.H., De Vries J.B., Liefers H., Tran N., and De Boer P. Evidence for activation of histamine H3 autoreceptors during handling stress in the prefrontal cortex of the rat. Synapse 43 (2002) 238-243
7. Willens T.E. Mechanism of action of agents used in Attention Deficit/Hyperactivity Disorder. J. Clin. Psychiatry 67 Suppl. 8 (2006) 32-37